
Immediately following the release of impressive full year financials, Ipsen CEO David Meek speaks on how the company is hitting …

David Meek has been appointed to the newly created position of chief commercial officer at the biotechnology firm Endocyte. Meek …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

